A derivative of amantadine with antiviral activity
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Rimantadine (hydrochloride)

Item No. 23838

Technical Information
Formal Name
α-methyl-tricyclo[3.3.1.13,7]decane-1-methanamine, monohydrochloride
CAS Number
1501-84-4
Synonyms
  • 1-(1-Adamantyl)ethylamine Hydrochloride
  • NSC 206764
Molecular Formula
C12H21N • HCl
Formula Weight
Purity
≥98%
A crystalline solid
DMF: 2 mg/mlDMSO: 50 mg/mlEthanol: 5 mg/mlPBS (pH 7.2): 5 mg/ml
λmax
202 nm
SMILES
NC(C)C12C[C@@H]3C[C@@H](C[C@@H](C3)C2)C1.Cl
InChi Code
InChI=1S/C12H21N.ClH/c1-8(13)12-5-9-2-10(6-12)4-11(3-9)7-12;/h8-11H,2-7,13H2,1H3;1H/t8?,9-,10+,11-,12?;
InChi Key
OZBDFBJXRJWNAV-LHRDWUBSSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    Rimantadine is a derivative of amantadine (Item No. 21364) with antiviral activity.1 It inhibits recombinant influenza A matrix protein 2 (M2) expressed in X. laevis oocytes (IC50 = 10.8 µM) and recombinant hepatitis C virus (HCV) p7 protein expressed in HEK293 cells (IC50s = 0.7, 24, 1.6, and 3.0 nM for HCV genotypes 1a, 2a, 3a, and 4a, respectively).2,3 Rimantadine inhibits cytotoxicity induced by the influenza A strains A/PR/8/34 (H1N1) and A/HK/7/87 (H3N2), but not the influenza B strain B/HK/72, in MDCK cells (EC50s = 18, 0.62, and >500 µM, respectively).4 It increases the survival rate of mice infected with the influenza A strain A2/Jap/305 from 20 to 90% when administered at a dose of 24 mg/kg two hours post-infection, with the survival rate decreasing when rimantadine is administered at longer timepoints following infection.5 It also has trypanocidal activity against bloodstream forms of T. brucei in vitro (IC50 = 1.26 µg/ml).6 Formulations containing rimantadine have been used in the prophylaxis and treatment of influenza A.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Bean, B. Antiviral therapy: Current concepts and practices. Clin. Microbiol. Rev. 5(2), 146-182 (1992).

    2. Wang, J., Ma, C., Wang, J., et alDiscovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus. J. Med. Chem. 56(7), 2804-2812 (2013).

    3. Breitinger, U., Farag, N.S., Ali, N.K.M., et alPatch-clamp study of hepatitis C p7 channels reveals genotype-specific sensitivity to inhibitors. Biophys J. 110(11), 2419-2429 (2016).

    4. Rey-Carrizo, M., Torres, E., Ma, C., et al3-Azatetracyclo[5.2.1.15,8.01,5]undecane derivatives: From wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant. J. Med. Chem. 56(22), 9265-9274 (2013).

    5. Rabinovich, S. Rimantadine therapy of influenza A infection in mice. Antimicrob. Agents Chemother. 1(5), 408-411 (1972).

    6. Kelly, J.M., Miles, M.A., and Skinner, A.C. The anti-influenza virus drug rimantadine has trypanocidal activity. Antimicrob. Agents Chemother. 43(4), 985-987 (1999).